Linezolid resistance in coagulase-negative staphylococci1 [4]

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 4, 2006, Pages 898-899

  Kelly, S ^a   Collins, J ^a,b   Davin, M ^a   Gowing, C ^a   Murphy, Philip G ^a,b  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Gram positive bacteria; ITU; Oxazolidinones

Indexed keywords

LINEZOLID;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CROSS INFECTION; DISEASE COURSE; DRUG USE; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT DURATION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; COAGULASE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33748690300     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl271     Document Type: Letter

References (5)

1. Jones RN, Ross JE, Fritsche TR et al. Oxazolidinone susceptibility patterns in 2004: Report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother 2006; 57: 279-87.
2. Mutnick AH, Enne V, Jones RN. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Ann Pharmacother 2003; 37: 769-74.
3. Ross JE, Anderegg TR, Sader HS et al. Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Diagn Microbiol Infect Dis 2005; 52: 53-8.
4. Bell JM, Turnidge JD, Ballow CH et al. Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific. J Antimicrob Chemother 2003; 51: 339-45.
5. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.